Trends in SARS-CoV-2 infection prevalence during England’s roadmap out of lockdown, January to July 2021
View ORCID ProfileOliver Eales, View ORCID ProfileHaowei Wang, View ORCID ProfileDavid Haw, View ORCID ProfileKylie E. C. Ainslie, View ORCID ProfileCaroline E. Walters, View ORCID ProfileChristina Atchison, View ORCID ProfileGraham Cooke, View ORCID ProfileWendy Barclay, View ORCID ProfileHelen Ward, View ORCID ProfileAra Darzi, View ORCID ProfileDeborah Ashby, View ORCID ProfileChristl A. Donnelly, View ORCID ProfilePaul Elliott, View ORCID ProfileSteven Riley
doi: https://doi.org/10.1101/2022.06.02.22275900
Oliver Eales
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
Haowei Wang
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
David Haw
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
Kylie E. C. Ainslie
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
11Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands
Caroline E. Walters
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
Christina Atchison
1School of Public Health, Imperial College London, UK
Graham Cooke
4Department of Infectious Disease, Imperial College London, UK
5Imperial College Healthcare NHS Trust, UK
6National Institute for Health Research Imperial Biomedical Research Centre, UK
Wendy Barclay
4Department of Infectious Disease, Imperial College London, UK
Helen Ward
1School of Public Health, Imperial College London, UK
5Imperial College Healthcare NHS Trust, UK
6National Institute for Health Research Imperial Biomedical Research Centre, UK
Ara Darzi
5Imperial College Healthcare NHS Trust, UK
6National Institute for Health Research Imperial Biomedical Research Centre, UK
7Institute of Global Health Innovation at Imperial College London, UK
Deborah Ashby
1School of Public Health, Imperial College London, UK
Christl A. Donnelly
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
3Department of Statistics, University of Oxford, UK
Paul Elliott
1School of Public Health, Imperial College London, UK
5Imperial College Healthcare NHS Trust, UK
6National Institute for Health Research Imperial Biomedical Research Centre, UK
8MRC Centre for Environment and Health, School of Public Health, Imperial College London, UK
9Health Data Research (HDR) UK London at Imperial College
10UK Dementia Research Institute at Imperial College
Steven Riley
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
Data Availability
Access to individual level REACT-1 data is restricted due to ethical and security considerations. Summary statistics and data, including the weighted daily number of positive tests and daily total number of tests, are available at https://github.com/mrc-ide/reactidd/tree/master/inst/extdata. Additional summary statistics and results from the REACT-1 programme are also available at https://www.imperial.ac.uk/medicine/research-and-impact/groups/react-study/real-time-assessment-of-community-transmission-findings/. REACT-1 study materials are available for each round at https://www.imperial.ac.uk/medicine/research-and-impact/groups/react-study/react-1-study-materials/.
Posted June 02, 2022.
Trends in SARS-CoV-2 infection prevalence during England’s roadmap out of lockdown, January to July 2021
Oliver Eales, Haowei Wang, David Haw, Kylie E. C. Ainslie, Caroline E. Walters, Christina Atchison, Graham Cooke, Wendy Barclay, Helen Ward, Ara Darzi, Deborah Ashby, Christl A. Donnelly, Paul Elliott, Steven Riley
medRxiv 2022.06.02.22275900; doi: https://doi.org/10.1101/2022.06.02.22275900
Trends in SARS-CoV-2 infection prevalence during England’s roadmap out of lockdown, January to July 2021
Oliver Eales, Haowei Wang, David Haw, Kylie E. C. Ainslie, Caroline E. Walters, Christina Atchison, Graham Cooke, Wendy Barclay, Helen Ward, Ara Darzi, Deborah Ashby, Christl A. Donnelly, Paul Elliott, Steven Riley
medRxiv 2022.06.02.22275900; doi: https://doi.org/10.1101/2022.06.02.22275900
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (679)
- Anesthesia (182)
- Cardiovascular Medicine (2685)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12318)
- Forensic Medicine (10)
- Gastroenterology (771)
- Genetic and Genomic Medicine (4161)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2699)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3935)
- Nursing (213)
- Nutrition (586)
- Oncology (2073)
- Ophthalmology (596)
- Orthopedics (243)
- Otolaryngology (308)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1131)
- Primary Care Research (462)
- Public and Global Health (6583)
- Radiology and Imaging (1424)
- Respiratory Medicine (877)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (55)
- Transplantation (191)
- Urology (170)